Comparison between Devyani International IPO and Windlas Biotech IPO.
Devyani International IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Windlas Biotech IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Devyani International IPO is up to ₹1,838.00 Cr whereas the issue size of the Windlas Biotech IPO is up to ₹401.54 Cr. The final issue price of Devyani International IPO is ₹90.00 per share and of Windlas Biotech IPO is ₹460.00 per share.
| Devyani International IPO | Windlas Biotech IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹5 per share |
| Issue Price (Lower) | ₹86.00 per share | ₹448.00 per share |
| Issue Price (Upper) | ₹90.00 per share | ₹460.00 per share |
| Issue Price (Final) | ₹90.00 per share | ₹460.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 165 shares | 30 shares |
| Fresh Issue Size | 4,88,88,888 shares | 35,86,956 shares |
| Fresh Issue Size (Amount) | up to ₹440.00 Cr | up to ₹165.00 Cr |
| OFS Issue Size | 15,53,33,330 shares | 51,42,067 shares |
| OFS Issue Size (Amount) | up to ₹1,398.00 Cr | up to ₹236.54 Cr |
| Issue Size Total | 20,42,22,218 shares | 87,29,023 shares |
| Issue Size Total (Amount) | up to ₹1,838.00 Cr | up to ₹401.54 Cr |
Devyani International IPO opens on Aug 04, 2021, while Windlas Biotech IPO opens on Aug 04, 2021. The closing date of Devyani International IPO and Windlas Biotech IPO is Aug 06, 2021, and Aug 06, 2021, respectively.
| Devyani International IPO | Windlas Biotech IPO | |
|---|---|---|
| Anchor Bid Date | Aug 03, 2021 | Aug 03, 2021 |
| Issue Open | Aug 04, 2021 | Aug 04, 2021 |
| Issue Close | Aug 06, 2021 | Aug 06, 2021 |
| Basis Of Allotment (Tentative) | Aug 11, 2021 | Aug 11, 2021 |
| Initiation of Refunds (Tentative) | Aug 12, 2021 | Aug 12, 2021 |
| Credit of Share (Tentative) | Aug 13, 2021 | Aug 13, 2021 |
| Listing date (Tentative) | Aug 16, 2021 | Aug 16, 2021 |
| Anchor Lockin End date 1 | Sep 10, 2021 | Sep 10, 2021 |
| Anchor Lockin End date 2 | Nov 09, 2021 | Nov 09, 2021 |
Devyani International IPO P/E ratio is , as compared to Windlas Biotech IPO P/E ratio of .
| Devyani International IPO | Windlas Biotech IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 75.79 | 78 | ||||
| Promoter Shareholding (Post-Issue) | 67.99 | 65.16 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹10822.71 Cr. | ₹1002.54 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Devyani International IPO Retail Individual Investors (RII) are offered 2,03,67,221 shares while in Windlas Biotech IPO retail investors are offered 2,03,67,221 shares. Qualified Institutional Buyers (QIB) are offered 6,11,01,666 shares in Devyani International IPO and 17,45,804 shares in Windlas Biotech IPO.
| Devyani International IPO | Windlas Biotech IPO | |
|---|---|---|
| Anchor Investor Reservation | 9,16,52,499 shares | 26,18,706 shares |
| Market Maker Reservation | ||
| QIB | 6,11,01,666 shares | 17,45,804 shares |
| NII | 3,05,50,832 shares | 13,09,354 shares |
| RII | 2,03,67,221 shares | 30,55,159 shares |
| Employee | 5,50,000 shares | |
| Others | ||
| Total | 20,42,22,218 shares | 87,29,023 shares |
Devyani International IPO subscribed 116.70x in total, whereas Windlas Biotech IPO subscribed 22.44x.
| Devyani International IPO | Windlas Biotech IPO | |
|---|---|---|
| QIB (times) | 95.27x | 24.40x |
| NII (times) | 213.06x | 15.73x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 39.48x | 24.22x |
| Employee (times) | 4.70x | |
| Other (times) | ||
| Total (times) | 116.70x | 22.44x |
